Immunology

Items 1-10 of 40

Page
per page
Set Descending Direction
  1. 20S Immunoproteasome (human) (untagged)
    SBB-PP0004
    SBB-PP0004-C02525 µg
    CHF 404.00
    20S Immunoproteasome vs. 20S Constitutive Proteasome Activity: 20S immunoproteasome is most active against Suc-LLVY-AMC (SBB-PS0010), Ac-PAL-AMC (SBB-PS0007), and Ac-ANW-AMC (SBB-PS0009) substrates, representing physiologically relevant chymotrypsi
  2. 20S Immunoproteasome (mouse) (untagged)
    SBB-PP0083
    SBB-PP0083-C02525 µg
    CHF 360.00
    20S Immunoproteasome (mouse) (untagged)
  3. 20S Immunoproteasome (rat) (untagged)
    SBB-PP0046
    SBB-PP0046-C05050 µg
    CHF 360.00
    20S Immunoproteasome (rat) (untagged)
  4. HA-Ubiquitin-propargylamide (human) (rec.) (HA)
    SBB-PS0124
    SBB-PS0124-C05050 µg
    CHF 366.00
    HA-Ubiquitin-propargylamide (human) (rec.) (HA)
  5. HA-Ubiquitin-vinyl methyl ester (human) (rec.) (HA)
    SBB-PS0123
    SBB-PS0123-C05050 µg
    CHF 366.00
    HA-Ubiquitin-vinyl methyl ester (human) (rec.) (HA)
  6. HA-Ubiquitin-vinyl pentyl sulfone (human) (rec.) (HA)
    SBB-PS0125
    SBB-PS0125-C05050 µg
    CHF 366.00
    HA-Ubiquitin-vinyl pentyl sulfone (human) (rec.) (HA)
  7. HA-Ubiquitin-vinyl sulfone (human) (rec.) (HA)
    SBB-PS0122
    SBB-PS0122-C05050 µg
    CHF 366.00
    HA-Ubiquitin-vinyl sulfone (human) (rec.) (HA)
  8. ISG15 (human) (rec.) (Rhodamine 110)
    SBB-PS0002
    SBB-PS0002-C05050 µg
    CHF 434.00
    Signal to Background. The signal to background ratio was determined by 100% hydrolysis of either 50nM or 500nM ISG15-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH7.5, 100mM NaCl, 1mM TCEP, 0.1mg/ml BSA.
  9. K11-linked Di-Ubiquitin (human) (rec.) (untagged)
    SBB-UP0063
    SBB-UP0063-C02525 µg
    CHF 184.00
  10. K11-linked Tetra-Ubiquitin (human) (rec.) (untagged)
    SBB-UP0064
    SBB-UP0064-C02525 µg
    CHF 278.00

Items 1-10 of 40

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.